The vaccine is a cell-associated live recombinant turkey herpesvirus (HVT) expressing the VP2 protein of infectious bursal disease virus and the gD and gI glycoproteins of infectious laryngotracheitis virus. The vaccine induces active immunity against infectious bursal disease (Gumboro disease), infectious laryngotracheitis and Marek’s disease in chickens.